Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DNMT1 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | SGCE | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | GLMN | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | PRPF4 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | RHBDF1 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | FCHSD1 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
mRNA | LRRC57 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | ATAD5 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | LSM7 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | PSIP1 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |